Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for '3tc hiv'
3tc hiv published presentations and documents on DocSlides.
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
Switch to PI/r + 3TC
by lois-ondreau
vs. PI/r . monotherapy. Study PIVOT. Study MOBID...
Switch to DRV/r + 3TC DUAL Study
by jireh
DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
by sophie
Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
by hazel
Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
by jocelyn
(CRPDDP). Training Contents. Module 1. : . HIV Ove...
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Antiretroviral Therapy (ART)
by alexa-scheidler
Dr. S . Ntshalintshali. Ngwelezana. hospital. N...
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Treatment of Children and Adolescents
by liane-varnes
Implementation Challenges. Annette H. Sohn, MD. T...
ART Initiation in Resource-Limited Settings
by lois-ondreau
Susan M. Graham . Assistant Professor, Medicine a...
Young person with multi-class resistance: follow-up and man
by luanne-stotts
(with perspectives from well-resourced and resour...
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
ClinicalTrials.gov
by lauren
Identifier: . NCT02770508 . Dual therapy based on ...
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
Missing formulations for paediatric HIV treatment and the Dakar Call for
by trish-goza
Action. Improving Access to Optimized Treatment ....
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
Fixed-Dose Combination of
by myesha-ticknor
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
Treatment-Experienced Patients in Resource-Limited Settings
by pasty-toler
Susan M. Graham . Assistant Professor, Medicine a...
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
by alida-meadow
Treating and Preventing HIV in 2019: Interactive ...
Track B Workshop Controversies in the Management of HIV-positive Adults:
by natalia-silvester
A Case-Based Approach. Sasisopin Kiertiburanakul,...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
Michael S. Saag , MD Professor of Medicine
by roxanne
Associate Dean for Global Health. University of Al...
Load More...